TSC2
WikiDoc Resources for TSC2 |
Articles |
---|
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on TSC2 at Clinical Trials.gov Clinical Trials on TSC2 at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on TSC2
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Directions to Hospitals Treating TSC2 Risk calculators and risk factors for TSC2
|
Healthcare Provider Resources |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Tuberous sclerosis protein 2, also known as TSC2 and Tuberin, is a human protein and gene.
Mutations in this gene lead to tuberous sclerosis. Its gene product is believed to be a tumor suppressor and is able to stimulate specific GTPases. The protein associates with hamartin in a cytosolic complex, possibly acting as a chaperone for hamartin. Alternative splicing results in multiple transcript variants encoding different isoforms of the protein.[1]
References
Further reading
- Jones AC, Shyamsundar MM, Thomas MW; et al. (1999). "Comprehensive mutation analysis of TSC1 and TSC2-and phenotypic correlations in 150 families with tuberous sclerosis". Am. J. Hum. Genet. 64 (5): 1305–15. PMID 10205261.
- Hengstschläger M (2002). "Tuberous sclerosis complex genes: from flies to human genetics". Arch. Dermatol. Res. 293 (8): 383–6. PMID 11686512.
- Hockenbery DM (2003). "Nailing down a link between tuberin and renal cysts". Am. J. Pathol. 162 (2): 369–71. PMID 12547695.
- Ramesh V (2004). "Aspects of tuberous sclerosis complex (TSC) protein function in the brain". Biochem. Soc. Trans. 31 (Pt 3): 579–83. doi:10.1042/ Check
|doi=
value (help). PMID 12773159. - Knowles MA, Hornigold N, Pitt E (2004). "Tuberous sclerosis complex (TSC) gene involvement in sporadic tumours". Biochem. Soc. Trans. 31 (Pt 3): 597–602. doi:10.1042/ Check
|doi=
value (help). PMID 12773163. - Ellisen LW (2007). "Growth control under stress: mTOR regulation through the REDD1-TSC pathway". Cell Cycle. 4 (11): 1500–02. PMID 16258273.
- Jozwiak J, Jozwiak S (2007). "Giant cells: contradiction to two-hit model of tuber formation?". Cell. Mol. Neurobiol. 27 (2): 251–61. doi:10.1007/s10571-006-9106-0. PMID 16897363.
- Cai SL, Walker CL (2007). "TSC2, a key player in tumor suppression and cystic kidney disease". Nephrol. Ther. 2 Suppl 2: S119–22. PMID 17373211.
- Urban T (2007). "[Pulmonary lymphangioleiomyomatosis with or without tuberous sclerosis]". Revue des maladies respiratoires. 24 (6): 725–40. PMID 17632432.